Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
J Korean Med Sci ; 37(27): e211, 2022 Jul 11.
Artigo em Inglês | MEDLINE | ID: mdl-35818702

RESUMO

BACKGROUND: Omalizumab is a very important drug for the treatment of chronic urticaria. Although omalizumab's therapeutic efficacy has been demonstrated, data on real-world experiences in Korea, especially regarding chronic inducible urticaria (CIndU), are limited. This study attempted to compare the efficacy of omalizumab in Korean chronic spontaneous urticaria (CSU) and CIndU patients. METHODS: Fifty-two CSU and 29 CIndU patients were included and Urticaria Activity Score 7 (UAS7) at baseline, week 4, and week 12 was assessed retrospectively. RESULTS: Omalizumab 150 mg significantly decreased UAS7 in both patients with CSU and CIndU with only one dose (P < 0.001). The significant decrease in the UAS7 scores of both groups of patients continued from weeks 4 to 12. Although there was no significant difference in treatment efficacy between the two groups, the symptoms of patients with CSU tended to improve faster; furthermore, the number of antihistamines administered daily reduced more significantly in this patient group (P = 0.047). Additionally, the decrease in the UAS7 score between baseline and week 12 and the response rate were higher in patients with CSU. CONCLUSION: Omalizumab may be slightly more effective against CSU than against CIndU. Regarding the CIndU subtypes, dermatographic urticaria was associated with the greatest reduction in the UAS7 score, and patients with this condition showed the highest response rate, indicating the best effect of omalizumab. The duration of chronic urticaria was greater in non-responders than in responders (P = 0.025). Conversely, baseline immunoglobulin E levels were significantly higher in responders (P = 0.039).


Assuntos
Antialérgicos , Urticária Crônica , Urticária , Antialérgicos/uso terapêutico , Doença Crônica , Urticária Crônica/tratamento farmacológico , Humanos , Omalizumab/uso terapêutico , Estudos Retrospectivos , Resultado do Tratamento , Urticária/diagnóstico , Urticária/tratamento farmacológico
3.
Ann Dermatol ; 35(Suppl 1): S48-S51, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37853864

RESUMO

A 75-year-old male was diagnosed with idiopathic pulmonary fibrosis and treated with pirfenidone. He presented with an erythematous thick scaly patch on his face, neck, and both hands and arms. He had a history of significant exposure to sunlight without using sunscreen. All lesions were restricted to sun-exposed areas and appeared one month ago. Histopathological examination revealed necrotic keratinocytes, epidermal spongiosis, liquefaction degeneration of the basal layer, interface dermatitis, solar elastosis, and upper dermal perivascular lympho-histiocytic infiltration. Based on clinical and histopathological findings, the skin lesion could be diagnosed as photosensitive drug eruption induced by pirfenidone. Pirfenidone was discontinued for a month, and the patient was treated with oral and topical corticosteroids. Consequently, the skin lesion almost fully cleared, leaving mild postinflammatory hyperpigmentation. Although there are many reports of photosensitivity reactions to pirfenidone, dermatologists are still not familiar with this drug. Through this case presentation, clinicians should be aware of the potential phototoxic effects of pirfenidone and provide the necessary precautionary information to patients who take pirfenidone.

4.
Ann Dermatol ; 35(Suppl 2): S323-S326, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38061731

RESUMO

A 63-year-old male presented with a painful skin lesion on the left side of the neck and upper chest approximately two months prior to presentation. Diffuse erythematous to purplish-colored sclerotic patches were observed. He had been treated with intravenous antibiotics for two weeks for cellulitis, but the lesion did not improve. Punch biopsy, and neck computed tomography (CT) with contrast enhancement were performed to differentiate between cellulitis and scleroderma. Histopathological examination revealed infiltration of pleomorphic and poorly differentiated tumor cells extending into thickened collagen bundles, and mitotic activity. Based on histologic and radiologic findings, the patient was suspected to have poorly differentiated carcinoma, and further evaluation of the origin of the carcinoma was performed. A subareolar mass on the left breast was observed on chest CT, and a needle biopsy was performed; results were consistent with findings from the skin biopsy. Finally, the patient was diagnosed with carcinoma en cuirasse, a subtype of cutaneous metastasis of breast cancer, was transferred to oncology, and underwent palliative chemotherapy.

5.
Indian J Dermatol ; 67(4): 324-327, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36578761

RESUMO

Background: Some alopecic diseases can be diagnosed by detailed history taking and physical examination, but in many cases, biopsy must be performed to make a definite diagnosis. Aims and Objectives: This study aimed to evaluate the clinico-pathological concordance of scalp lesions showing alopecia. Materials and Methods: We retrospectively reviewed the electronic medical records and biopsy slides of patients who underwent biopsy for evaluating scalp lesions showing alopecia. Based on the definitions of clinico-pathological concordances, scalp alopecic disease was evaluated. Results: A total of 121 patients were enrolled in the study. A total of 203 clinical differential diagnoses were made before performing a biopsy. Thirty-one patients showed full concordance, and 58 patients showed partial concordance; thus overall concordance was shown in 89 patients (73.55%). Folliculitis decalvans and alopecia areata showed a higher full concordance rate than average (P < 0.05), whereas dissecting folliculitis showed a lower overall concordance rate than average, and folliculitis decalvans showed a higher overall concordance rate than average (P < 0.05). The overall concordance rate of alopecia areata was 100% (P = 0.061). Conclusion: In diagnosing folliculitis decalvans and alopecia areata, which showed high full and overall concordance, performing a biopsy to make a definite diagnosis is not always necessary, especially when patients show typical clinical features. Dissecting folliculitis, which showed low overall concordance, was less likely to be suspected as a clinical differential diagnosis, making it difficult to distinguish based on clinical findings alone. Therefore, when it is suspected, a detailed evaluation including a biopsy is recommended.

6.
Indian J Dermatol ; 67(3): 312, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36386109

RESUMO

Background: Joint replacement is an important surgery for replacing a damaged joint with prosthesis. Implants used for joint replacement are made of metal, plastic, and ceramic. Skin reactions, such as dermatitis, can occur due to a hypersensitivity to these external substances. Aims: The aim of this study was to find the relationship between joint replacement and dermatitis. Methods: A nationwide population-based retrospective cohort study was performed using the National Health Insurance Service Database of the Republic of Korea. A total of 40,218 patients who underwent joint replacement were enrolled as the operation group and 40,218 controls were also enrolled. A cox proportional hazard regression model, and Fine and Gray regression model were used to compare the risk of dermatitis between the two groups. Results: Dermatitis occurred in 9.2% of the operation group and 9.1% of the control group, and no statistical difference was observed between the two groups. According to the Cox proportional hazard regression model, and Fine and Gray regression model, the risk of dermatitis did not increase in the operation group compared to that in the control group. However, the risk of dermatitis increased 1.20-fold in the operation group compared to that in the control group aged <60 years according to the Fine and Gray regression model (95% confidence index (CI) = 1.05-1.37, P = 0.0008). Conversely, no difference in dermatitis risk was observed between the two groups aged ≥60 years. Conclusions: We found that the risk of dermatitis increased after joint replacement in those aged <60 years.

7.
Zootaxa ; 4661(3): zootaxa.4661.3.3, 2019 Aug 29.
Artigo em Inglês | MEDLINE | ID: mdl-31716697

RESUMO

As a result of the study of the hoverfly subtribe Xylotina in Korea, we have recognized the following 14 Xylota species, including eight new to the Korean syrphid fauna (marked with asteristks) and three new to science: X. abiens, X. amaculata*, X. atricoloris*, X. coquilletti, X. filipjevi*, X. fo*, X. ignava, X. pseudoignava*, X. spurivulgaris*, X. tarda*, X. umbrosa*, X. hauseri sp. n., X. orientiflorum sp. n., and X. xanthotarsis sp. n. Among these species, we clarified the identities of three previously confused species, X. coquilletti, X. spurivulgaris and X. fo, which had been collectively identified as a single species, X. coquilletti, in the Korean literature. In addtion, we provided unequivocal characters to separate two sibling species pairs based on their external characters including genitalic structure (X. hauseri sp. n. vs. X. umbrosa; X. pseudoignava vs. X. xanthotarsis sp. n.; X. filipjevi vs. X. tarda). In order to aid accurate identification of the Korean Xylota, diagnoses, descriptions, and color photographs of external structures including male genitalia are provided. For the taxonomic key, we included all the Korean genera of the subtribe Xylotina (Xylota, Brachypalpus and Chalcosyrphus).


Assuntos
Dípteros , Animais , Masculino , República da Coreia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA